The data suggested that PLOD2 was associated with poor prognosis of lung cancer patients (Figure 1a), especially in lung adenocarcinoma patients (Figure 1b) but not in lung squamous cell carcinoma patients (Figure 1c). The gene discussed is PLOD2; the disease is lung cancer.